-
-
-
-
-
-
-
Wolfe Research Starts Mirum Pharmaceuticals (MIRM) at Outperform
-
-
-
-
-
-
-
Mirum Pharamceuticals (MIRM) PT Raised to $58 at H.C. Wainwright
-
-
-
-
-
-
-
Mirum Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Mirum Pharmaceuticals Submits European Marketing Authorization Application for Maralixibat in Alagille Syndrome Supported by New Positive Results from Natural History Study Comparison
-
-
-
-
-
-
-
Mirum Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call on August 5, 2021
-
-
-
-
-
-
-
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Mirum Pharmaceuticals to Report First Quarter 2021 Financial Results and Host Conference Call on May 6, 2021
-
15,684 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

